BioNJ's 26th Annual Dinner Meeting & Innovation Celebration to Honor New Jersey's Innovators and the Patients and Advocates Who Inspire Them

News provided by

Jan 03, 2019, 16:44 ET

TRENTON, N.J., Jan. 3, 2019 /PRNewswire/ -- Considered the kickoff event of the year for the life sciences industry, BioNJ's 26th Annual Dinner Meeting & Innovation Celebration will take place Thursday, February 7, 2019 at the Hilton East Brunswick. More than 700 biotechnology and pharmaceutical professionals, academic leaders, service providers and government officials will come together to honor the groundbreaking medical innovation coming from the Garden State.

"Because Patients Can't Wait®, we are so proud of New Jersey's robust life sciences ecosystem that was responsible for numerous new FDA novel drug approvals in 2018, reinforcing the fact that New Jersey is the drug development capital of the world," said BioNJ President and CEO Debbie Hart. "Our Members are helping Patients live longer, better lives and we are pleased to celebrate their important work and dedication in this way."

The evening will include the presentation of the twelfth annual Dr. Sol J. Barer Award for Vision, Innovation and Leadership to Dr. William Hait, Global Head, Johnson & Johnson, External Innovation by Dr. Sol J. Barer. The Dr. Sol J. Barer Award was established in 2008 by the BioNJ Board of Trustees to recognize outstanding leaders who've made significant contributions to the life sciences industry in New Jersey and around the world.

"As a trained medical oncologist and a globally-recognized expert in translational cancer research, Dr. Hait's work has touched millions of Patients throughout the State and around the world," said Hart. "We are elated to honor Dr. Hait for his tireless work on behalf of Patients and New Jersey's growing life sciences ecosystem."

Amicus Therapeutics' Chief Patient Advocate, Jayne Gershkowitz and ten-year old Patient Advocate Max Schill will receive the second annual "Heart of BioNJ" Award in honor of their dedication and selfless work on behalf of Patients.

Advanced Accelerator Applications (a Novartis Co.), Allergan, Amicus Therapeutics, Eli Lilly, GSK, Helsinn, Insmed, Kyowa Kirin, Janssen Biotech, Merck & Co., Otsuka America, Regeneron, Sanofi, Shionogi Inc., Sun Pharmaceutical and Teva Pharmaceutical will be honored with Innovator Awards for each receiving novel FDA drug approvals from the U.S. Food and Drug Administration (FDA) in 2018.

The evening features a cocktail reception from 4:30 p.m.-6:00 p.m., dinner program from 6:00 p.m.-8:30 p.m. ending with a dessert reception from 8:30 p.m.-9:30 p.m.

Pricing for BioNJ Members and BIO affiliated organizations is $445. Future Member pricing is $575. Click here to register.

Click here to learn about Sponsorship opportunities. More information can be found at www.BioNJ.org.

CONTACT: Randi Bromberg, 609-890-3185, [email protected]

SOURCE BioNJ